{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:58:02Z","timestamp":1790506682923,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijantimicag.2012.07.007","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T17:31:22Z","timestamp":1346520682000},"page":"458-462","source":"Crossref","is-referenced-by-count":68,"title":["In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae"],"prefix":"10.1016","volume":"40","author":[{"given":"Sarah","family":"Hemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Brehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0005","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1017\/S0031182007003198","article-title":"Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis","volume":"134","author":"Hemphill","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00430-010-0154-1","article-title":"The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host\u2013parasite interaction","volume":"199","author":"Brehm","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2009.11.001","article-title":"Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans","volume":"114","author":"Brunetti","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/bies.20662","article-title":"Protein tyrosine kinases as new potential targets against human schistosomiasis","volume":"29","author":"Dissous","year":"2007","journal-title":"Bioessays"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug","volume":"1","author":"Capdeville","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijpara.2010.01.007","article-title":"Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro","volume":"40","author":"Beckmann","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0035","doi-asserted-by":"crossref","first-page":"42325","DOI":"10.1074\/jbc.M110.210336","article-title":"Characterization of the Src\/Abl hybrid kinase SmTK6 of Schistosoma mansoni","volume":"286","author":"Beckmann","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-3024.2011.01319.x","article-title":"Cestode genomics\u2014progress and prospects for advancing basic and applied aspects of flatworm biology","volume":"34","author":"Olson","year":"2012","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpara.2009.10.009","article-title":"Molecular characterisation of MEK1\/2- and MKK3\/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox tapeworm Echinococcus multilocularis","volume":"40","author":"Gelmedin","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0050","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ijpara.2007.11.002","article-title":"Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles","volume":"38","author":"Spiliotis","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bcp.2008.08.020","article-title":"Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors","volume":"76","author":"Gelmedin","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0060","first-page":"4236","article-title":"Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)","volume":"62","author":"Nagar","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0065","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","article-title":"The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR\u2013ABL-positive cells","volume":"90","author":"Deininger","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-009-0779-4","article-title":"Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example","volume":"66","author":"Li-Wan-Po","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2012.07.007_bib0075","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3390\/molecules14104166","article-title":"Design and synthesis of novel 2-phenylaminoprimidine (PAP) derivatives and their antiproliferative effects in human chronic myeloid leukemia cells","volume":"14","author":"Chang","year":"2009","journal-title":"Molecules"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T02:58:24Z","timestamp":1594609104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912003123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0924857912003123"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.07.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}